Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene.

We have identified a large kindred with severe serum HDL cholesterol deficiency. The proband, a 65-year-old woman, had greatly diminished concentrations of serum HDL cholesterol (0.19 mmol/L) and apolipoprotein (apo) A-I (21.9 mg/dL). HDL cholesterol and apo A-I levels were similarly reduced in all affected family members, while apo A-II levels were about half of those in the nonaffected family members. Pedigree analysis suggested a dominant inheritance pattern of the phenotype. Sequence analysis of the exons and exon-intron boundaries of the apo A-I gene revealed heterozygosity for a single T-to-G point mutation substituting arginine for leucine at residue 159 of the mature apo A-I protein (apo A-IFin). The T-to-G substitution destroys an Fsp I cleavage site, permitting direct polymerase chain reaction/restriction enzyme analysis of the mutation. All the affected family members were shown to be heterozygous for the apo A-IFin mutation. Isoelectric focusing revealed the presence of the mutant apo A-IFin protein in both serum and HDL of the affected subjects. Functional consequences of the mutation were examined by expressing the mutated and wild-type apo A-I cDNAs in COS-7 cells. The mutant apo A-I mRNA had a size similar to that of the normal mRNA, and both mutant and wild-type apo A-I proteins were secreted into the cell media. In vivo kinetic studies of apo A-I revealed increased catabolism in affected subjects. In conclusion, we describe a novel point mutation of the apo A-I gene, apo A-IFin, causing a dominantly negative phenotype as regards serum HDL levels, possibly due to increased catabolism of apo A-I.

[1]  A. von Eckardstein,et al.  A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[2]  P. Shah,et al.  Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. , 1994, Circulation.

[3]  A. von Eckardstein,et al.  A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. S. Ranu Relief of DNA polymerase stop(s) due to severity of secondary structure of single-stranded DNA template during DNA sequencing. , 1994, Analytical biochemistry.

[5]  Lawrence A Leiter,et al.  Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. , 1994, The Journal of clinical investigation.

[6]  Hao Li,et al.  Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  K. Lackner,et al.  High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene. , 1993, The Journal of clinical investigation.

[8]  T. Arinami,et al.  Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein A-I gene. , 1993, Biochemical and biophysical research communications.

[9]  J. Lee,et al.  Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships. , 1993, Journal of Biological Chemistry.

[10]  A. Tall,et al.  Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. , 1993, The Journal of clinical investigation.

[11]  D. Rader,et al.  Familial HDL deficiency due to marked hypercatabolism of normal apoA-I. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  I. Goldberg,et al.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. , 1993, The Journal of clinical investigation.

[13]  G. Assmann,et al.  High Density Lipoproteins, Reverse Transport of Cholesterol, and Coronary Artery Disease Insights From Mutations , 1993, Circulation.

[14]  G. Franceschini,et al.  In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia. , 1993, The Journal of clinical investigation.

[15]  W. J. Johnson,et al.  Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. , 1992, Journal of lipid research.

[16]  S. Grundy,et al.  Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. , 1992, Journal of lipid research.

[17]  C. Fielding,et al.  Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding. , 1992, The Journal of biological chemistry.

[18]  P. Hawkins,et al.  Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Hinrich Abken,et al.  A procedure to standardize CAT reporter gene assay , 1992, Nucleic Acids Res..

[20]  H. Gylling,et al.  Non-cholesterol sterols, absorption and synthesis of cholesterol and apolipoprotein A-I kinetics in a Finnish lecithin-cholesterol acyltransferase deficient family. , 1992, Atherosclerosis.

[21]  N. Seidah,et al.  Proprotein and prohormone convertases of the subtilisin family Recent developments and future perspectives , 1992, Trends in Endocrinology & Metabolism.

[22]  D. Rader,et al.  In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. , 1992, Journal of lipid research.

[23]  R. Krauss,et al.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.

[24]  S. Deeb,et al.  A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins. , 1991, The Journal of biological chemistry.

[25]  A. Tall,et al.  Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. , 1991, The Journal of biological chemistry.

[26]  S. Grundy,et al.  Evaluation of a method for study of kinetics of autologous apolipoprotein A-I. , 1991, Journal of lipid research.

[27]  K. Yamakawa,et al.  Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Yokoyama,et al.  Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.

[29]  S. Eisenberg,et al.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.

[30]  M. Uhlén,et al.  Bidirectional solid-phase sequencing of in vitro-amplified plasmid DNA. , 1991, BioTechniques.

[31]  A. von Eckardstein,et al.  Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. , 1991, Journal of lipid research.

[32]  R. Gregg,et al.  A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. , 1990, Genomics.

[33]  A. von Eckardstein,et al.  Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. , 1990, The Journal of biological chemistry.

[34]  A. von Eckardstein,et al.  Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. , 1989, The Journal of clinical investigation.

[35]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[36]  J. Ordovás,et al.  Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. , 1989, The Journal of biological chemistry.

[37]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[38]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[39]  E. Ferris,et al.  DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Dobiášová,et al.  Cold labelled substrate and estimation of cholesterol esterification rate in lecithin cholesterol acyltransferase radioassay. , 1986, Physiologia Bohemoslovaca.

[41]  E. Bosisio,et al.  Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns. , 1985, Atherosclerosis.

[42]  S. Karathanasis Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Utermann,et al.  Apolipoprotein A‐IGiessen (Pro143→Arg) , 1984 .

[44]  E. Schaefer Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. , 1984, Arteriosclerosis.

[45]  R. Mahley,et al.  Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type. , 1984, The Journal of biological chemistry.

[46]  A. Kornblihtt,et al.  Gene structure of human apolipoprotein A1. , 1983, Nucleic acids research.

[47]  R. Mahley,et al.  Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. , 1983, The Journal of biological chemistry.

[48]  G. Assmann,et al.  Papers and Notes on I I Methodology One-step Screening Method for the Polymorphism of Apolipoproteins A-i, A-11, and A-iv , 2022 .

[49]  W. Rutter,et al.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R. Mahley,et al.  A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. , 1980, The Journal of clinical investigation.

[51]  R. Mahley,et al.  DECREASED HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVELS WITH SIGNIFICANT LIPOPROTEIN MODIFICATIONS AND WITHOUT CLINICAL ATHEROSCLEROSIS IN AN ITALIAN FAMILY , 1980 .

[52]  C. Blum,et al.  Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. , 1978, The New England journal of medicine.

[53]  W. Fitch Phylogenies constrained by the crossover process as illustrated by human hemoglobins and a thirteen-cycle, eleven-amino-acid repeat in human apolipoprotein A-I. , 1977, Genetics.

[54]  A. Mclachlan,et al.  Repeated helical pattern in apolipoprotein-A-I , 1977, Nature.

[55]  E. Southern Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[56]  U. Schibler,et al.  Changes in size and secondary structure of the ribosomal transcription unit during vertebrate evolution. , 1975, Journal of molecular biology.

[57]  A. Gotto,et al.  A molecular theory of lipid—protein interactions in the plasma lipoproteins , 1974, FEBS letters.

[58]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins. , 1972, Biochimica et biophysica acta.

[59]  C. Fielding,et al.  A protein cofactor of lecithin:cholesterol acyltransferase. , 1972, Biochemical and biophysical research communications.

[60]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[61]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[62]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[63]  C. Matthews,et al.  The theory of tracer experiments with 131I-labelled plasma proteins. , 1957, Physics in medicine and biology.